| Literature DB >> 4000165 |
U H Ehling, D J Charles, J Favor, J Graw, J Kratochvilova, A Neuhäuser-Klaus, W Pretsch.
Abstract
The multiple endpoint mammalian mutagenesis approach developed in our institute screens in the same animal for recessive specific-locus alleles at 7 loci, approximately 30 loci coding for dominant-cataract mutations, 23 loci controlling protein-charge changes and 12 loci for enzyme-activity alterations. Experiments to screen for the approximately 70 loci in the same offspring of treated male mice were performed with ethylnitrosourea (ENU), procarbazine and X-ray exposure. Mutations were recovered for each genetic endpoint in all treatment groups where a sufficient number of offspring was scored. ENU treatment is highly effective in inducing mutations to all genetic endpoints. The mutations were confirmed by breeding tests. The mutation rates to specific-locus and enzyme-activity alleles were both higher than the mutation rates to either dominant-cataract or protein-charge alleles. The advantages and possibilities of the multiple endpoint approach are discussed in detail.Entities:
Mesh:
Substances:
Year: 1985 PMID: 4000165 DOI: 10.1016/0027-5107(85)90136-8
Source DB: PubMed Journal: Mutat Res ISSN: 0027-5107 Impact factor: 2.433